BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12538032)

  • 1. Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells.
    Jonsson CA; Carlsten H
    Int Immunopharmacol; 2003 Jan; 3(1):31-7. PubMed ID: 12538032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inosine monophosphate dehydrogenase (IMPDH) inhibition in vitro suppresses lymphocyte proliferation and the production of immunoglobulins, autoantibodies and cytokines in splenocytes from MRLlpr/lpr mice.
    Jonsson CA; Carlsten H
    Clin Exp Immunol; 2001 Jun; 124(3):486-91. PubMed ID: 11472413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolic acid inhibits inosine 5'-monophosphate dehydrogenase and suppresses production of pro-inflammatory cytokines, nitric oxide, and LDH in macrophages.
    Jonsson CA; Carlsten H
    Cell Immunol; 2002; 216(1-2):93-101. PubMed ID: 12381354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.
    Stet EH; De Abreu RA; Bökkerink JP; Lambooy LH; Vogels-Mentink TM; Keizer-Garritsen JJ; Trijbels FJ
    Ann Clin Biochem; 1994 Mar; 31 ( Pt 2)():174-80. PubMed ID: 7914720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effect of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil on survival and severity of glomerulonephritis in systemic lupus erythematosus (SLE)-prone MRLlpr/lpr mice.
    Jonsson CA; Svensson L; Carlsten H
    Clin Exp Immunol; 1999 Jun; 116(3):534-41. PubMed ID: 10361247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
    Vethe NT; Bergan S
    Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
    Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
    Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of mycophenolate mofetil.
    Ransom JT
    Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil and its mechanisms of action.
    Allison AC; Eugui EM
    Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic Acid by GTP.
    Ji Y; Gu J; Makhov AM; Griffith JD; Mitchell BS
    J Biol Chem; 2006 Jan; 281(1):206-12. PubMed ID: 16243838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolic acid upregulates miR-142-3P/5P and miR-146a in lupus CD4+T cells.
    Tang Q; Yang Y; Zhao M; Liang G; Wu H; Liu Q; Xie Y; Li D; Dai Y; Yung S; Chan TM; Lu Q
    Lupus; 2015 Aug; 24(9):935-42. PubMed ID: 25661834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
    Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
    Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
    Yashima Y; Ohgane T
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection.
    Nakanishi T; Morokata T; Kubo K; Umeno H; Eikyu Y; Kozuki Y; Seki N
    Int Immunopharmacol; 2010 Jan; 10(1):91-7. PubMed ID: 19840872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic actions of mycophenolic acid.
    Morath C; Schwenger V; Beimler J; Mehrabi A; Schmidt J; Zeier M; Muranyi W
    Clin Transplant; 2006; 20 Suppl 17():25-9. PubMed ID: 17100698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
    Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
    Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.